Last reviewed · How we verify
Monovalent Frozen FluMist® — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
Monovalent Frozen FluMist® (Monovalent Frozen FluMist®) — MedImmune LLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Monovalent Frozen FluMist® TARGET | Monovalent Frozen FluMist® | MedImmune LLC | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Monovalent Frozen FluMist® CI watch — RSS
- Monovalent Frozen FluMist® CI watch — Atom
- Monovalent Frozen FluMist® CI watch — JSON
- Monovalent Frozen FluMist® alone — RSS
Cite this brief
Drug Landscape (2026). Monovalent Frozen FluMist® — Competitive Intelligence Brief. https://druglandscape.com/ci/monovalent-frozen-flumist. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab